Advertisement

Advertisement

2019 AACR-AHNS Head and Neck Cancer Conference

Immunotherapy
Head and Neck Cancer

Head and Neck Cancer Immunotherapy in Locally Advanced Disease: Clinical Trial Updates

Programmed cell death protein 1 (PD-1) inhibitors are approved for the second-line treatment of head and neck cancer and likely will be soon in the first-line treatment of locally advanced disease. Ac...

Advertisement

Advertisement



;
Advertisement